{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:54:47Z","timestamp":1790488487102,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.semnephrol.2005.05.016","type":"journal-article","created":{"date-parts":[[2005,11,21]],"date-time":"2005-11-21T20:24:29Z","timestamp":1132604669000},"page":"435-439","source":"Crossref","is-referenced-by-count":66,"title":["Treatment of Hypertension in Chronic Kidney Disease"],"prefix":"10.1016","volume":"25","author":[{"given":"Robert D.","family":"Toto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2005.05.016_bib1","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1681\/ASN.V7122658","article-title":"Predialysis systolic blood pressure correlates strongly with mean 24-hour systolic blood pressure and left ventricular mass in stable hemodialysis patients","volume":"7","author":"Conion","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2005.05.016_bib2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/ajh\/2.4.259","article-title":"Microalbuminuria and casual and ambulatory blood pressure monitoring in normotensives and in patients with borderline and mild essential hypertension","volume":"2","author":"Gianconi","year":"1989","journal-title":"Am J Hypertension"},{"key":"10.1016\/j.semnephrol.2005.05.016_bib3","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/01.HYP.36.5.894","article-title":"Ambulatory blood pressure monitoring and organ damage","volume":"36","author":"Mancia","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2005.05.016_bib4","first-page":"275","article-title":"Ambulatory blood pressure monitoring in end-stage renal disease","volume":"2","author":"Peixoto","year":"1997","journal-title":"Blood Press Monit"},{"key":"10.1016\/j.semnephrol.2005.05.016_bib5","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease","volume":"288","author":"Wright","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2005.05.016_bib6","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJM199403313301301","article-title":"The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease","volume":"330","author":"Klahr","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2005.05.016_bib7","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes","volume":"317","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.semnephrol.2005.05.016_bib8","doi-asserted-by":"crossref","first-page":"9R","DOI":"10.1016\/S0002-9149(98)00750-4","article-title":"Antihypertensive therapy in type 2 diabetes","volume":"82","author":"Estacio","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.semnephrol.2005.05.016_bib9","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1046\/j.1523-1755.2002.00213.x","article-title":"Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes","volume":"61","author":"Schrier","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2005.05.016_bib10","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/ki.1995.361","article-title":"\u201cStrict\u201d blood pressure control and progression of renal disease in hypertensive nephrosclerosis","volume":"48","author":"Toto","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2005.05.016_bib11","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/S0197-2456(96)00081-5","article-title":"Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) pilot study","volume":"17","author":"Wright","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.semnephrol.2005.05.016_bib12","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease","volume":"288","author":"Wright","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2005.05.016_bib13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1523-1755.2000.00165.x","article-title":"Plasma lipids and risk of developing renal dysfunction","volume":"58","author":"Muntner","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2005.05.016_bib14","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/ki.1997.29","article-title":"Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans","volume":"51","author":"Fogo","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2005.05.016_bib15","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0272-6386(00)70017-5","article-title":"Cigarette smoking is associated with augmented progression of renal insufficiency in severe essential hypertension","volume":"35","author":"Regalado","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2005.05.016_bib16","first-page":"54","article-title":"Smoking","volume":"26","author":"Ritz","year":"2000","journal-title":"Diabet Med"},{"key":"10.1016\/j.semnephrol.2005.05.016_bib17","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0272-6386(00)70017-5","article-title":"Cigarette smoking is associated with augmented progression of renal insufficiency in severe essential hypertension","volume":"35","author":"Regalado","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2005.05.016_bib18","doi-asserted-by":"crossref","first-page":"I80","DOI":"10.1161\/01.HYP.13.5_Suppl.I80","article-title":"Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program","volume":"13","author":"Shulman","year":"1989","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2005.05.016_bib19","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/01.HYP.25.4.587","article-title":"Early predictors of 15-year end-stage renal disease in hypertensive patients","volume":"25","author":"Perry","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2005.05.016_bib20","doi-asserted-by":"crossref","first-page":"629","DOI":"10.7326\/0003-4819-134-8-200104170-00007","article-title":"Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril","volume":"134","author":"Mann","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2005.05.016_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.7326\/0003-4819-140-1-200401060-00006","article-title":"The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease","volume":"140","author":"Muntner","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2005.05.016_bib22","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1523-1755.2004.00797.x","article-title":"Treating anemia early in renal failure patients slows the decline of renal function","volume":"66","author":"Gouva","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2005.05.016_bib23","unstructured":"National Kidney Foundation: KDOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 43:9-10, 1004"},{"key":"10.1016\/j.semnephrol.2005.05.016_bib24","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2005.05.016_bib25","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2005.05.016_bib26","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1056\/NEJM199604113341502","article-title":"Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency","volume":"334","author":"Maschio","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2005.05.016_bib27","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0140-6736(96)11445-8","article-title":"Gissen Group","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2005.05.016_bib28","doi-asserted-by":"crossref","first-page":"244","DOI":"10.7326\/0003-4819-139-4-200308190-00006","article-title":"Progression of chronic kidney disease: The role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: A patient-level meta-analysis","volume":"139","author":"Jafar","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2005.05.016_bib29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.7326\/0003-4819-135-2-200107170-00007","article-title":"Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data","volume":"135","author":"Jafar","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2005.05.016_bib30","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1046\/j.1523-1755.2001.0600031131.x","article-title":"Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease","volume":"60","author":"Jafar","year":"2001","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.semnephrol.2005.05.016_bib31","doi-asserted-by":"crossref","first-page":"342","DOI":"10.7326\/0003-4819-142-5-200503010-00009","article-title":"The effect of a lower target blood pressure on the progression of kidney disease","volume":"142","author":"Sarnak","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2005.05.016_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1056\/NEJM200101043440101","article-title":"Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet","volume":"344","author":"Sacks","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2005.05.016_bib33","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1681\/ASN.V9112096","article-title":"Effects of dihydropyridine calcium channel blockers, angiotensin-converting enzyme inhibition, and blood pressure control on chronic, nondiabetic nephropathies. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN)","volume":"9","author":"Ruggenenti","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2005.05.016_bib34","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/archinte.163.13.1555","article-title":"Effects of blood pressure level on progression of diabetic nephropathy","volume":"163","author":"Bakris","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semnephrol.2005.05.016_bib35","doi-asserted-by":"crossref","first-page":"249A","DOI":"10.1016\/S0735-1097(02)81115-9","article-title":"Eplerenone reduces proteinuria in type II diabetes mellitus","volume":"39","author":"Epstein","year":"2002","journal-title":"J Am Coll Cardiol"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929505001117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929505001117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T03:26:14Z","timestamp":1626751574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929505001117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0270929505001117"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2005.05.016","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}